Company Info
Phone(617) 315-4600
Year Established
2013
Ticker
CRSP
Exchange
NASDAQ
Contacts
Samarth Kulkarni, Ph.D.Chair, President & CEO
Jon Terrett
Head of Research
James Kasinger
General Counsel
Raju Prasad, Ph.D.
CFO
Alex Harding, M.D., M.B.A.
Head of Business Development
Company Description
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
